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Abstract 
 
The unique properties of Quantum Dots (QDs) such as broad excitation spectra, narrow 
emission spectra, high resistance to photobleaching, higher photo-stability and stronger 
fluorescence makes them one of the most attractive fluorescent reporter molecules for a 
wide range of biological applications including biosensing and assay development 
applications. However, the high cost of QDs has limited their application in assay 
development where at least 50-100µL reagents are required for performing an assay. This 
research capitalizes on the superior properties of QDs by utilizing just 1-2µL of sample 
and antibodies conjugated to QDs for detection of biomarkers. In this work we developed 
a simple and inexpensive microcapillary immunosensor based on quantum dot assay for 
detecting Myeloperoxidase (MPO) in animal stool samples. The method utilizes 
commercially available polymethylmethaacrylate (PMMA) micro-capillaries (I.D. 
250µm, O.D. 500µm) as substrates for performing a sandwich assay. The results obtained 
indicate that the limit of detection (LOD) of the device and the assay is 100 picomolar of 
MPO (~15 ng/mL) in 1-2µL of sample. The specificity of the assay was tested in a 
solution mixture containing MPO and Matrix Metalloproteinase 1 (MMP 1).  
Furthermore, the assay and device robustness was tested by detecting MPO in animal 
stool samples and comparing the results obtained with a commercially available MPO 
ELISA kit which uses 100µL of sample. 
viii 
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1. Introduction to Biosensors 
1.1 Overview 
 
A sensor in its true sense is a bridge in the gulf between stimuli and the response. 
Biological Sensors are those conduits which decode the information sent by one system 
of the body and communicate with another system to react to the information. Variant 
examples spread over glucose production, reflex motion, and hormone secretion in 
interaction with the external environment. A biosensor is in effect an artificial sensor with 
a biological component attached intermittently to mimic the action of a naturally evolved 
algorithm. The most common example of a sensor is a sensory organ such as the nose and 
an example of a manmade sensor is the litmus paper for measuring pH1. A sensor 
primarily comprises of 3 components: a recognition unit, a transduction unit and a signal 
processing unit. The recognition component detects the presence of the substance to be 
measured, called the analyte. Once the analyte is detected the transduction unit or 
transducer, transforms the interaction of the recognition unit and the analyte to a 
measurable/quantifiable signal. The signal from the transducer is converted to a 
meaningful result by the signal processing unit2. Figure 1 shows the basic components of 
a sensor. 
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In a sensor, the signal produced can be transduced in various forms. The usual forms 
include thermal, electrical and optical1, 2 signals. In the case of thermal transducers, a 
change in temperature is measured. Electrical transducers can measure a change in 
voltage or in the number of electrons (current) corresponding to different responses.. In 
optical transducers, a change in the number of photons is measured to assess the sensor’s 
response.  
A device which integrates a biological element on to assess a specific interaction with a 
signal transducer is called a Biosensor3. In a biosensor, the recognition unit is usually a 
biological component such as an Antibody, an Antigen, an Enzyme or an array of cells. 
The use of these biological components makes the sensors specific for a particular 
analyte/substance. These types of sensors are often referred to as Affinity Sensors4.  
 
 
Figure 1:  Schematic Representation of the Components of a Sensor1-3 
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A subclass of affinity sensors is that of immunosensors, which use immunological 
principles for detection purposes. In immunosensors, specific antibody / antigen 
interactions are exploited. The specificity and affinity of antibody-antigen interaction has 
allowed researchers to develop assays for a particular biomarker of interest.  
Antibodies are gamma globulin proteins produced in the bodies of vertebrates in response 
to an alien stimulus. An alien stimulus can be any foreign body which in biological 
parlance is called an antigen. Antibodies have a fascinating property of combining with 
the antigens which have triggered their production. Antibodies are produced by the cells 
of the immune system called the B-Cells. Hence, these antibodies protect our body from 
various microbes, infections and help fight various diseases. When the immune system 
 
Figure 2: Schematic representation of the elements of an immunosensor1-3 
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recognizes an antigen it induces a response which converts the B-Cells into plasma cells. 
These plasma cells secrete antibodies into the blood stream to help eliminate the antigens. 
The antibody which is usually secreted in response to an antigen is Immunoglobulin G 
(IgG)5.The structure of the antibody is shown in Figure 3. All antibodies have a specific 
binding site for an antigen and this binding site varies between antibodies produced in 
response to antigens. The presence of the antigen binding site (epitope) makes the 
antibody-antigen reaction highly specific. This specificity is utilized in immunosensors.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3:  Structure of Antibody (Adapted from Immunology by Kuby)5 
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In an immunosensor, various assay methodologies can be used to detect the antigen. For 
e.g., direct immunosensors, competitive immunosensors, sandwich immunosensors, 
displacement immunosensors etc4. Figure 4 shows the different types of immunosensors 
mechanisms. Our research is focused on developing an optical biosensor for detection of 
Myeloperoxidase (MPO). The work primarily focused on developing a sandwich micro-
immunosensor utilizing fluorescent nano-particles (Quantum Dots) as the reporting 
moieties.  
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Various assay formats used in immunosensors4. 
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1.1.1 Optical Biosensors 
 
Optical biosensors transduce optical signals resulting from biological interactions6.  The 
optical signal produced is directly proportional to the concentration of the biological or 
chemical analyte7.  The past decade or so has seen an exponential increase in the number 
and range of available biosensors based on different optical phenomena. Optical 
biosensors are based on different type of optical phenomena, for e.g. 
electrochemiluminescence, fluorescence, interferometry, phosphorescence, absorption, 
planar waveguides, evanescent waves, surface plasmon resonance (SPR), etc6. Recent 
advances in instrumentation combined with breakthroughs in experimental design have 
led to the increasing application of optical biosensors in many areas6, 8.  
Optical fibers were the first optical transducers which were used to develop a biosensor. 
Optical fibers act as waveguides for the transmission of optical signals6.  One of the first 
optical fiber based sensor was described about 25 years ago by Freeman and Seitz9. 
Briefly, the sensor system used a 2 feet-long optical fiber with a 1/8 inch diameter fiber 
optic cable. One end of the cable was used to carry out the chemiluminescence reaction 
and the other end was used to detect the chemiluminescence signal resulting from the 
conversion of peroxide to peroxidase by a photomultiplier tube (PMT)10.  
After the advent of the first optical fiber biosensor, many different optical fiber 
biosensors have been developed for different areas of research such as environmental11, 
12, clinical13, 14, detection of heavy metals15, 16 etc. Salama et al reported development of 
an optical fiber based chemiluminescent immunosensor for the detection of autoimmune 
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antibodies against ovarian and breast cancer-associated antigens. The group successfully 
detected antibodies against GIPC-1, a protein involved in regulation of G-Protein 
signaling. The research primarily focused on the development of an immunosensor for 
detecting human monoclonal 27.B IgM in patients suffering from ovarian/breast cancer. 
The immunosensor’s Limit of Detection (LOD) was 30 pg/mL, which is 50 times lower 
than the traditional 96 well ELISA assay13.  
Another class of optical biosensors which has been used widely are Surface Plasmon 
Resonance (SPR) sensors. SPR sensors measure the refractive index changes occurring at 
the surface of a metal film supporting a surface plasmon17. The most popular SPR system 
is the BIAcoreTM instrument from Biacore3. The BIAcoreTM instrument has been used to 
study the specificity, kinetics, and binding affinity of antibody-antigen reactions.  
Two other popular categories of optical biosensors include capillary based optical 
biosensors and microfluidic based optical biosensors. Both these system use micro level 
of reagent volumes. Hence, these two categories of sensors can be termed as “Optical 
Micro-Immunosensors”. The focus of this research is the development of a capillary 
optical immunosensor utilizing fluorescence for the detection of an antigen analyte. 
1.1.1.1  Microfluidic Immunosensors 
 
Microfluidic immunosensors comprise of micron level channels where the immunoassay 
reaction takes place. The most common assays used are sandwich assays followed by 
competitive assays for small molecules18. The primary components in microfluidic 
devices are the micro-channels. These micro-channels reduce the volume of reagents to 
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be used to only a few micro liters. Microfluidic based immunosensors offer several 
advantages over their 96 well plate counterparts. The advantages are listed below18-20: 
1. Less Reagents and Smaller Sample Volumes: Micro-channels, the primary 
components in microfluidic devices enable the user to perform immunoassays by 
using volumes less than 10 micro-liters.  This reduction in the use of reagents and 
samples results in significant cost reduction because most of the antibodies, 
fluorescent molecules and other reagents for immunoassay are very costly.  
2. Reduced Analysis Time: The small dimensions of micro-channels reduce the 
diffusion distance between the antibody immobilized on the solid substrate and 
the antigen present in the liquid phase. The reduction in diffusion distance results 
in the reduction of antibody-antigen reaction time. Hence, this can reduce the 
analysis time from a few hours to a few minutes. 
3. Automation and Integration: Microfluidic devices can be made fully automated 
by using proper pumps and valves to transport the liquid. This automation helps to 
reduce errors which are inherent in lab based bench top immunoassays.  
Integration of small reagent storage chambers into microfluidic devices allows 
them to be used as point of care diagnostic devices. The small volumes of liquids 
in a biochip can be moved by capillary actions, thus making the device portable, 
automated and easy to use19.  
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Owing to their advantages microfluidic devices have been used widely for 
biological sensing purposes and have been successfully integrated with optical 
components20. Current applications includes the analysis of clinically relevant 
biomarkers such as C-reactive protein (CRP)21, interleukin-6 (IL-6)22, 23, prostate 
specific antigen (PSA)24 and others. 
Klostranec et al, 25 successfully integrated microfludics, optics and use of 
quantum dots in their work. They demonstrated the superior performance of their 
device by detecting blood borne infectious disease markers in blood serum. They 
were able to detect markers for Hepatitis C, B and HIV. The sample volume used 
was less than 100µL and the assay time was less than one hour. In this research 
work, the biomarkers (antigens) are covalently attached to the surface of the 
Qdots and subsequent sandwich assay was performed by incubation with alexa 
fluor 488 conjugated antibodies. This was followed by passing the Qdot complex 
through the microfluidic channel exposed to a laser spot (488nm and 25mW). The 
fluorescence signal generated was collected by a 60x oil immersion objective with 
a numerical aperture of 1.35. The collected signal is passed on to a solid state 
photodetector where a change in the voltage is measured to check the presence of 
the antigen. Even though the limit of detection of this system was 10-12 M, the 
system used expensive optical components and photodetectors to detect the 
presence of antigens. In our research work, we report an inexpensive optical set 
up utilizing UV LEDs and a monochrome CCD camera with a limit of detection 
of 100 picomolar.  
10 
 
Diercks et al26 reported development of a microfluidic device which can detect 
multiple protein markers in a sensitive and quantitative way in nano-liters 
volumes of sample by using optically encoded microsphere beads.  
 
 
 
 
 
 
 
 
The success of microfluidic immunosensors in research labs has been translated into 
commercial products with ease. One such example is “Triage Meter” from Biosite 
Incorporation. A fluorescent probe is used for detection of various cardiac markers, 
toxicity test and drug abuse test. A 5 milliwatt laser is used to excite the fluorophores and 
a silicone photodiode is used to detect the fluorescence signal. Figure 5 below shows a 
picture of the Triage Meter, composed of  two primary components : theMicrofluidic 
Chips and a read out unit27. 
 
Figure 5: Triage Meter Panel (Adapted From Biosite Inc Website)27 
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1.1.1.2 Capillary Biosensors 
 
Capillaries have found extensive application in numerous disciplines of science, ranging 
from electronics to semiconductors, from manufacturing to biological sampling & 
detection methods, like chromatography28.  The versatility of a capillary comes from its 
geometry, its high surface area to volume ratio, possibility to use a transparent 
construction material and create a surface with perfect adhesion29.  
A sturdy minuscule capillary construction allows the immunosensor device to be compact 
and portable; the small size ensures easy and accurate detection even for very small 
samples size, with combined cost - effectiveness because the small sample reduces the 
amount of expensive reagents required.  A larger surface to volume ratio in a capillary 
compared to the geometry of wells in well-plates (currently used as standards), can 
accelerate the detection reactions  and increase sensitivity, by reducing the role of 
diffusion30. Capillary based biosensors can eliminate the complex process of 
microfabrication required for microfluidic immunosensors. It is all these characteristics 
that make capillary an excellent choice for construction of a cost-effective immunoassay 
device. 
Capillary tubes can act as both optical waveguide and sampling chambers. The 
cylindrical shape facilitates easy and uninterrupted flow-in and flow-out of samples and 
the inner surface can be used for immobilization of probing molecules such as 
antibodies31.  
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Both glass and polymer based capillaries have been used to carry out immunoassays. 
Specifically glass or fused silica18, 32-34, polystyrene35, polymethylpentene36, 
polymethylmethacrylate37, poly-vinyl chloride38 have been used in fabricating capillary 
biosensors. Polymeric tubes may pose a manufacturing challenge and glass capillary 
tubes need additional processing steps of surface activation for successful fixation and 
immobilization of probes.   
The inert nature of glass makes it necessary to perform additional chemical modification 
to form covalent bonds between a glass surface and a biomolecule. Chemicals used for 
such modification / functionalization comprise of silinazing agents like 3-mercaptopropyl 
trimethoxysilane.  These silanizing agents bind simultaneously to the hydroxy groups on 
the glass silicate surface and to various groups on the probe surface ranging from the 
amino terminal to, thiol groups, based upon the specific silanizing agent34. Therefore, the 
choice of these silinazing agents depends upon the type of immunoassay that they are 
going to be used in and the probes that they need to attach to.  
On the other hand, polymeric capillaries are of particular interest due to readily available 
functional groups on their surface offering an appropriate substrate for immobilizing 
antibodies or antigens, without special modification steps. Furthermore, recent 
developments in photochemical methods of functionalizing polymeric materials provide 
compelling reasons to choose polymeric capillaries over fused silica or glass capillaries39, 
40.  
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Several strategies have been devised to detect low concentrations of antigens by solid 
phase immunoassay in capillaries, primarily focusing on excitation of fluorophores 
followed by collection of the emitted photons. One such approach takes advantage of the 
evanescent field at the interface of the polymer/liquid interface for collecting the emitted 
signal; this particular method requires the material of the capillary to function as a 
waveguide28.   
The first capillary waveguide application for a sensor was reported in 1994 by Weigl and 
Wolfbeis 41. The chemical sensor measured carbon dioxide. Substances which produce a 
color change when they come in contact with carbon dioxide were immobilized on the 
inner surface of the capillary. Optical fibers were used for both excitation and collection. 
Both the excitation and collection fiber were perpendicular to the capillary. 
In 2002, Ligler et al 42 provided a summary on four different potential excitation and 
collection methods for integrating waveguide capillaries.  
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One of the techniques (Figure 6, Method 3) is analogous to methods used in this research 
project. An evanescent wave is used for excitation of bound fluorophores. Fluorescent 
emission can be collected at the end of the capillary by propagating it down the axis 
(Figure 6, Method 2 and 4). Alternatively, a detector can be placed perpendicular to the 
axis of the capillary for data collection (Figure 6, Method 3). The later method was used 
in this research to detect fluorescence from the capillary. 
 
Figure 6: Four Different Excitation and Fluorescence method 
collection demonstrated by Ligler et al42 
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Several biosensors utilize the integrating waveguide capillary biosensor design with data 
collection from the ends of the capillary. Zhu et al reported development of a capillary 
based waveguide sensor for detection of E. coli O15743. The method described utilized a 
capillary based sandwich immunoassay for detecting the presence of E. coli O157. In this 
work, the signal from the capillary is integrated over the length of the capillary and the 
signal was detected at one end of the capillary (Figure 6, Method 4). The volume of 
sample used in this case was 75µL.  
Recently, Stringer et al44 reported a capillary biosensor based on Forster Resonance 
Energy Transfer (FRET). The sensor utilized the superior properties of Quantum Dot 
Fluorescent particles and a Teflon AF capillary as a Liquid Core Waveguide to detect the 
presence of Troponin I in solution as well as in biological samples. This work used a 
laser system for excitation of the fluorophores and used the capillaries as integrated 
waveguide demonstrated in Method 4 of Figure 6. The limit of detection of the sensor 
was 32nM in solution for troponin I and 55nM in spiked human plasma.   
In this work we are reporting a low cost PMMA microcapillary biosensor using Quantum Dots as 
the fluorescent probes for detection of picomolar quantities of analytes, and demonstrating this 
capability by detecting Myeloperoxidase (MPO) in solutions and animal samples.  Our selection 
of PMMA was based on its optical properties and the capability to selectively functionalize its 
surface for covalently immobilizing antibodies.  
1.2 Fluorescence 
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Fluorescence is widely employed in biology for both imaging and detection assays. 
Advances in optics hardware and availability of more sensitive fluorescent probes for 
conjugation to antibodies and antigens have enabled continuous improvement in 
fluorescence based imaging and detection. The molecules which exhibit the phenomenon 
of fluorescence are called fluorophores. Most fluorophores are organic molecules. These 
molecules absorb light at a certain wavelength, resulting in excitation of an electron. The 
excited electron moves to a higher energy level from the ground state. The excited 
electron starts emitting photons while returning back to the ground state. The emission of 
this photon results in fluorescence45. The Jablonski diagram (Figure 7) depicts the 
process of fluorescence46.  
 
 
 
 
 
 
 
 
 
 
Figure 7: Simplified Jablonski diagram depicting the phenomena 
of fluorescence 46 
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Examples of organic fluorophores include fluorescein, rhodamine, Alexa Fluor.  Despite 
their wide usage they pose several challenges.  For example, the organic dyes 
photobleach in confocal laser scanning microscopy, because of the high power laser used 
for excitation. Other disadvantages include poor photo stability, narrow absorption 
spectra and broad emission spectra. Owing to these issues the organic dyes pose 
limitations in their usage for quantitative biological detection, such as in sensitive assays. 
Semiconductor based fluorephores such as the Quantum Dots (QDs) offer an attractive 
alternative.  
1.2.1 Quantum Dots 
 
The advent of advanced engineering capabilities in areas exploring complex and highly 
intelligent facets of biology has opened big vistas into understanding the core architecture 
and working of science. Nanotechnology is one of the greatest advances of modern 
science exploring the same. One key application of nanotechology is the development of  
luminescent nano sized particles. The most popular fluorescent nanoparticles for 
biological application are Quantum Dots47. At nanometer scale these charged carriers 
(electrons/holes) exhibit quantum confinement effect at room temperature and give rise to 
material properties that not only differ from their bulk form but can also be fine tuned by 
controlling their quantum yield48. The size of the nano-particle controls the emission 
spectrum, while UV light excites all quantum dots. Hence, by selecting the size of the 
particles, QDs with different emission spectra can be synthesized47. 
18 
 
QDs exhibit several advantages over organic fluorophores. These advantages include 
broad excitation spectra stretching into the ultraviolet (UV) region, narrow emission 
spectra, large Stokes Shift, high resistance to photobleaching, higher photo-stability and 
stronger fluorescence49.  
Multiplexing, although an attractive way to detect multiple markers, has remained a 
challenge in organic fluorophores due to bleed through in the emission bands and the 
requirement of multiple excitation sources. Solutions include expensive hardware and 
software combinations such as those used in expensive Flow Cytometry Instruments 
(FACS). On the contrary, the broad excitation spectra in QDs allow multiplexing with 
Quantum Dots with a single excitation source and their narrow emission spectra address 
the issue of overlapping emission spectra which existent is organic fluorophores50.  
Figure 8 (adapted from the Invitrogen website) shows the emission spectra of different 
QDs51.  
Extreme level of resistance to photobleaching allows QDs to be employed in various 
systems where high power excitation sources are used, for e.g., confocal laser scanning 
microscopy. It has been reported that QDs exhibit 100 times more stability to 
photobleaching than their organic fluorophores counter parts52. 
This higher photo-stability of QDs is crucial for experiments where continuous 
fluorescence measurements are required, for example in live cell imaging for monitoring 
particular cellular trafficking events53. The stronger and brighter fluorescence properties 
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of QDs help in overcoming the auto-fluorescence signal that is particularly high in the in 
vivo conditions52, 54.  
 
 
 
 
 
 
 
 
 
 
QDs are semiconductor nanoparticles which comprise of a core shell structure. Two of 
the most widely used commercial QDs come with a core of CdSe or CdTe and a shell of 
ZnS and emissions from 405nm to 805nm50, 52. The shell stabilizes the structure, helps to 
overcome quenching compared to a QD made only from a core and provides a large 
surface area available for further modification. 
 
 
Figure 8: Spectra of QDs with different emission wavelength with same 
excitation wavelength of 405nm.  
L to R: QD525, QD565, QD605, QD655, QD700. The numbers denote the emission 
wavelength (Adapted from Invitrogen Website51). 
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In order to make QDs suitable for biological imaging and use in a biological environment 
they also have to be rendered water soluble. This is done by capping the shell with a 
polymer layer that contains a hydrophobic segment facing inside towards the shell and a 
hydrophilic segment facing outside. The hydrophilic layer can be modified to include 
functional groups such as –COOH and –NH2 groups for further conjugation to proteins 
and antibodies or oligonulceotides52, 53, 55. 
 
Figure 9: Excited Quantum Dot Particles exhibiting fluorescence  (Adapted 
from Invitrogen Website51). 
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QD conjugation to biomolecules is achieved by different ways like electrostatic binding, 
non covalent biotin-streptavidin bonding or covalent bonding. Figure 9 shows the 
different ways of conjugating biomolecules to QDs56. The most widely used conjugation 
technique of all is the covalent bond formation between the QDs surface and 
biomolecules. Surface modifications on QDs allow easier covalent bond formation. In 
one of the most widely used methods, amine terminated QDs are used for conjugating 
antibodies. The amine terminated QDs are activated with a malemide containing 
crosslinker molecule which can be then conjugated to a fragment or whole antibody 
molecule. Some of the most commonly employed QD conjugation methods are based on 
 
Figure 10: Schematic of QD structure attached to a biomolecule 
(Adapted from Invitrogen Website 51). 
22 
 
crosslinking reactions between amine and sulfhydryl groups, between carboxylic acid and 
amine group, between aldehyde and hydrazide functions. The carboxylic-amine bond has 
one advantage over all other methods; this method doesn't require any modification of the 
antibody before QD conjugation. In case of amine and sulfhydryl bond formation, the 
antibody should be reduced to expose their interchain -SH bonds. In the case of aldehyde 
and hydrazide bonds, carbohydrate groups on the Fc portion of the antibody are oxidized. 
These modifications on antibodies may affect their performance to a certain extent. Xing 
et al compared the performance of various QD-conjugation methods for 
immunohistochemical staining. Table 1 shows the summary of properties and 
performance of the different QD-Ab conjugates they evaluated for immunohistochemical 
staining56. 
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Figure 11:  Schematic showing different bioconjugation methods used to conjugate 
antibodies/proteins to QDs56 
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In this research sulfhydryl conjugation method was used. The reason for using this 
conjugation method was mainly due to its availability in the market and medium cost. 
Applications of QDs encompass many areas  including single cell labeling and imaging, 
 
Conjugation 
Method 
Sulfhydryl 
 
Amide Fc-Sugar Biotin-Avidin 
Bond Type Covalent Covalent Covalent Non-covalent 
Conjugated 
Ligand 
Ab fragments Whole Ab Whole Ab Whole Ab 
Site 
Specificity 
Yes No Yes No 
Ligand 
Orientation 
Fixed Random Fixed Both depending 
on biotinlyation 
condition 
Ab/QD ratio ~4 ~15 ~15 < 3 
Background 
Noise 
Low Medium Low Low 
Reagent Costs Medium Low Medium High 
Overall 
Performance 
Fair Poor Excellent Good 
 
Table 1: Characteristics and performance of different QD-Ab conjugation 
methods56 
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imaging of signaling pathways, deep tissue imaging, in vivo tumor and cancer imaging, 
immunosensor development, assay labeling  as well as their use as FRET donors57. 
Kerman et al, reported a QD based immunosensor for the detection of prostate-specific 
antigen58. A disposable substrate with carbon on surface was used to carry out a sandwich 
assay. Primary antibody was immobilized on the substrate surface and the antigen was 
captured by a biotinylated secondary Ab. The detection was done by introducing 
Streptavidin QD. The limit of detection of this immunosensor in serum was 0.25 ng/mL. 
QDs have also been used in protein microarrays for early detection of cancer. In one such 
application, Zajac et al reported detection of TNF, IL-6, IL-8, MIP-1β, IL-13 and IL-1β at 
picomolar concentrations59.  
Quantum dots (QDs) have also found significant applications in biology especially in live 
cell imaging 60 and to follow and understand signaling pathways 61. Due to their excellent 
properties QDs were selected in this project for developing a capillary based 
immunosensor.  
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2. RESEARCH OBJECTIVE 
 
The objective of this research was to develop a low cost Polymer Microcapillary 
biosensor using QDs as the fluorescent reporting molecules. As mentioned earlier, 
current organic dyes have many limitations when it comes to biosensors and multiplexing 
applications. In order to overcome these limitations, QDs were used in this research. The 
main disadvantage of QDs is their high cost. In order to address this issue, we developed 
a “polymer microcapillary” sensor using just 1-2 µL of sample and QD-Ab solution. 
PMMA was selected for the capillary material because of its superior optical properties 
and ease of surface modification for antibody/antigen immobilization on its surface. 
Several optical sensing methods were evaluated during the project and compared for 
detecting bioanalytes. The detection capability of the sensor was demonstrated by using 
myeloperoxidase (MPO), an inflammatory marker over-expressed in all inflammatory 
diseases including those of the gastrointestinal tract. Desired capabilities of the biosensor 
include fast, accurate and reliable detection of MPO and inexpensive optical set up for 
detection. In this research, Light Emitting Diodes (LEDs) were used, which are a 
significantly less expensive than LASER based systems. 
The goals of this research can be summarized as: 
• Demonstrate detection of a bioanalyte, MPO in this case, at picomolar 
concentrations using 1-2µL volume of sample. 
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•  Develop a sandwich immunoassay using Quantum Dots as fluorescent reporting 
molecules. 
• Develop an inexpensive optical detection system for reliable fluorescence 
detection. 
• Demonstrate the ability to detect MPO in biological samples, specifically animal 
stool samples of a disease simulating human IBD. 
 A key reason for selecting MPO to demonstrate the performance of the capillary 
microimmunosensor is the availability of an animal model where inflammation can be 
induced to produce MPO in animal stool samples. This model has been in use by Dr. 
Murthy for years62 and the ability to detect MPO in tissue samples of diseased animals 
through QD technology has been previously demonstrated by our research group63. 
The final goal of this project is to develop a fully automated multi-microcapillary set up 
for fast and reliable detection of biomarkers. The research work presented here forms the 
basic foundation of this goal.  
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3. Myeloperoxidase 
Introduction 
 
Myeloperoxidase (MPO) is a peroxidase enzyme present in neutrophil granulocytes. It is 
an abundant leukocytic enzyme and the heme segment of its structure gives it its greenish 
characteristic color64.  It is a liposomal protein seen in neutrophils rich body secretions 
such as pus and mucus. It is also found in minute quantities in macrophages and 
monocytes64, 65.  
Production 
 
MPO is expressed by a 14kb gene which consists of 11 introns and 12 exons. The gene is 
located on the long arm of chromosome 17 in the segment q12-24. A 80 kDa preproMPO 
is the  first product of translation. This preproMPO is processed the endoplasmic 
recticulum to produce active proMPO. The proMPO is exported into the Golgi 
compartment. This propeptide is processed in the azurophilic granules66. 
Structure 
 
MPO is a heme enzyme of two dimers each of which contains heme prosthetic groups 
with equal reactivity to Hydrogen peroxide.MPO is known to be strongly cationic 67. 
MPO is a 146 kDa dimer connected by a single disulphide bridge between each unit. 
Each unit of the dimer consists of two polypeptides, one light chain (108 amino acids; 
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14.5 kDa) and one heavy chain (466 amino acids; 58.5 kDa)66. Figure 12 shows the 3D 
structure of Human Myeloperoxidase with heme complex68.Three isoforms of MPO are 
in prevalence, and they vary only in the size of the heavy chains66, 69.  
 
 
 
 
 
 
 
 
 
 
 
Current Relevance 
 
MPO plays a primary role in the immune response during the inflammation caused by the 
protective ring of the host’s defense mechanism. High levels of MPO in serum have been 
related to higher risk of coronary disease occurence70. MPO has been shown to be present 
 
Figure 12: Structure of Human Myeloperoxidase Complex with Heme Complex68 
30 
 
in the atherosclerotic lesions71. The MPO/H2O2/HOCL system along with the nitric 
oxide is responsible for the oxidation of low density lipoprotein (LDL). This modified 
LDL is uptaken by macrophages resulting in the formation of foam cells. Modified LDL 
also interferes with the biological activity of nitric oxide (NO) as a vasodilator triggering 
platelet activation72. 
Elevated level of MPO has been found in stool samples of patients suffering from various forms 
Inflammatory Bowel Disease like ulcerative colitis and Crohn’s disease73, 74.  
In this research work MPO was used to demonstrate the functionality of a QD based 
microcapillary sensor and complements the work of Karwa et al who demonstrated the 
presence of MPO in the colitis tissue of an animal model and the correlation of MPO 
expression to inflammation and disease progression63. Stool samples obtained from the 
same animal (mouse) model were used in this work to demonstrate the capability of the 
QD based microcapillary sensor to detect MPO ex-vivo. 
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4. MATERIALS AND METHODS 
4.1 Materials 
 
The capillaries used in this study were obtained from Paradigm Optics Inc (O.D. 500 
microns, I.D. 250 microns). In order to prevent “buckling” of the polymer capillaries and 
be able to hold them straight, we used in the beginning of our studies glass capillaries 
from World Precision Instruments, Sarasota, FL, USA. Later, a customized system based 
on spring loaded system was developed to hold the capillary straight. Rabbit anti Human 
polyclonal MPO antibody was purchased from ABD Serotec, Raleigh, NC, USA and this 
antibody is used to coat the polymer surface. Zero length cross linkers 1-Ethyl-3-[3-
dimethylaminopropyl]carbodiimide (EDC) and N-hydroxysuccinimide (NHS) were 
obtained from Pierce Biotechnology Inc., IL, Rockford, USA. Monoclonal anti – Human 
MPO antibody and antigen MPO were obtained from LEE Biosolutions, St. Louis, 
Missouri, USA. Fetal Bovine Serum (FBS), 10X Phosphate Buffer Saline, Sodium Azide, 
Peristaltic Pump and its accessories were obtained from Fisher Scientific, Pittsburg, PA. 
EDTA, Tween 20, Protease Inhibitor and Glycerol were obtained from Sigma Aldrich. 
Quantum Dot Conjugation Kit was obtained from Invitrogen Corporation, Fredrick, 
Maryland. The Syringe Pump was obtained from KD Scientific Holliston, MA. UV 
curable glue was obtained from Edmund Optics, Barrington, NJ.  
The animal stool samples were provided by Mr. Kalyan Chakravarthy and Dr. Sreekant 
Murthy. 
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4.1.1 Optical Components 
 
For excitation of the QDs UV-LEDs with two different output power were obtained from 
Nichia Corp. The UV-LEDs used had optical output power of 10 mW and 300 mW 
respectively. A long pass filter and a band pass filter (600±20 nm) were obtained from 
Edmund Optics, Barrington, NJ. A monochrome CCD camera (COHU 4900) was 
purchased from Cohu Inc., San Diego, CA and a firewire monochrome CCD camera 
(Stingray, AVT-FS-033B) purchased from 1stVision Incorporated, Andover, MA.  
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4.2 Methods 
4.2.1. Quantum Dot Conjugation 
 
Quantum Dots were conjugated to antibodies according to the protocol provided by 
Invitrogen Corporation. Briefly, the amine terminated QDs were activated by a 
heterobifunctional crosslinker 4-(maleimidomethyl)-1-cyclohexanecarboxylic acid N-
hydroxysuccinimide ester (SMCC). The antibodies were reduced using DTT 
(Dithiothreitol) exposing the thiol groups (- SH) from the broken disulfide bridges. The 
activated QDs and the reduced antibody fragments were then brought to react to form the 
conjugate. Unconjugated antibodies and QDs were removed from the conjugated QD-
Abs by running the whole mixture through a separation column. For each conjugation, 
125µL of 8µM amine terminated QDs and 300µL of 1mg/mL monoclonal antibody was 
used. Each conjugation procedure yields approximately 200µL of conjugates of 
approximately 1µM concentration. 
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4.2.2 Capillary Functionalization and MPO Assay 
 
Functionalization of PMMA capillaries (pCaps) was carried out by following an alkaline 
ester hydrolysis of methacrylate, a method adapted from Bai et al. for functionalizing 
PMMA 75. The method was modified slightly, 1N NaOH at 60°C was pumped through 
the pCaps using a peristaltic pump at 100µL/min for one hour followed by washing with 
1X PBS buffer (pH 7.4). This step hydrolyzes the acrylate ester group on the surface of 
the pCAP resulting in COOH termination. The availability of COOH functional groups is 
utilized to covalently bind the MPO polyclonal antibody to the inner walls of the 
capillary.  Functionalized pCAPs were then treated with EDC/NHS solution (104.7mM 
EDC 21.7mM NHS) in PBS pH 6.0 for 5 hours40. The activation was followed by 
removal of excess EDC/NHS by washing the pCaps with 1X PBS pH 7.4. After this, the 
capillaries were loaded with 100nM MPO polyclonal antibody. Optimal immobilization 
of the polyclonal MPO antibody on the inner surface of the pCAP was accomplished by 
incubation at 4°C for 16 hours.  Non-immobilized antibodies were then removed from the 
capillary by washing with a buffer containing 0.05% Tween and 0.03% sodium azide in 
1X PBS pH 7.4 at a flow rate of 50µL/min using a syringe pump. Each capillary was 
washed with 30µL of wash buffer in each step. Subsequently, a blocking buffer 
containing 2% FBS in 1X PBS pH 7.4 buffer was introduced into the capillaries for 1 
hour at room temperature to block the vacant sites and prevent non-specific binding. 
MPO solutions at different concentrations or processed animal samples were then 
introduced into the pAb immobilized capillaries and allowed to interact with the pAb for 
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one hour at room temperature followed by injection of the wash buffer 1X PBS pH 7.4 
containing 0.01% tween. QD conjugated mAb (QD-Ab) at 100nM concentration was 
then introduced into the pCAP, incubated at room temperature for one hour followed by 
washing with the wash buffer 1X PBS pH 7.4 containing 0.05% Tween. The fluorescence 
intensity of the QD-Ab from the capillaries was captured either using a fluorescent 
microscope or a monochrome CCD camera.  
Several capillaries were imaged to evaluate and optimize the immobilization and reaction 
conditions by fluorescence microscopy (Leica DMRX upright fluorescence microscope) 
or CCD camera. Calibration curves were generated using known dilutions of MPO and 
this allowed us to determine the lowest limit of detection (LOD) of the whole assay.  The 
amount of fluid inside the capillary was restricted to 1-2 µL by limiting the length of the 
capillary. The assay was then carried out to determine its sensitivity and selectivity for 
detecting MPO in solution and in animal stool samples. Figure 13 illustrates the entire 
protocol of the assay and Figure 14 summarizes the steps of the sandwich assay followed. 
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Figure 13: Steps of the assay for Myeloperoxidase Detection 
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Figure 14: Schematics of the Antibody Immobilization and Sandwich Assay 
inside the capillary set up 
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4.2.3. Optical Detection Set Up 
 
In this project, three different optical detection set ups were evaluated. Two out of these 
three configurations provided useful results and could be used for the assay. During the 
development of the optical set up, LEDs with two different optical outputs were used. 
One LED had a 10mW optical output whereas the other had a 300mW optical output. The 
10mW LED will be referred to as “Low Power LED (LPLED)” and the 300Mw LED will 
be referred to as “High Power LED (HPLED)” in the rest of this thesis. The three optical 
configurations evaluated were: 
1. Waveguide Illumination Mode 
2. Multiple UV-LED Array 
3. Side-Illumination Mode 
4.2.3.1 Waveguide Illumination Mode 
 In this configuration, each PMMA capillary (pCAPs) was inserted in a larger glass 
capillary for experiments where the capillary will act as waveguides. Excitation of QDs 
was achieved by coupling the UV light through the ends of the capillary; light propagates 
through the walls of the capillary tube exciting the QDs within the evanescent field. 
Figure 15 shows the schematics of this configuration, which was tested using both Low 
Power (LPLED) and High Power (HPLED) LEDs.  
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In the case of LPLED, a three axis manual micromanipulator was used to align the capillary 
along the axis of the LED to ensure maximum coupling of light for QD excitation.  In this case a 
long pass filter was used to cut the excessive UV light and a cylindrical mirror was used to collect 
the scattered fluorescent light. The images for various concentrations of QD dilutions were 
captured using the COHU 4900 camera. 
 
 
 
 
 
 
 
 
In the case of HPLED, the UV LED was aligned using a three axis micromanipulator to couple 
the light into the capillary. In this case, no cylindrical mirror was used to collect the scattered 
light. The images for various concentrations of QD dilutions were captured using the Sting Ray 
Camera. 
 
 
 
Figure 15: Schematic Illustration of Waveguide Illumination Mode 
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4.2.3.2 Side Illumination Mode 
This illumination mode was employed using just the High Power LED. This illumination 
mode was employed for High Power LED because the key components which were 
 
Figure 16: Low Power LED Waveguide Illumination Mode 
Configuration 
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identified to improve the signal to noise ratio included use of high power LED, Side 
Illumination mode and a better camera (Sting Ray Camera). An aspheric lens with a focal 
length of 6 mm (f=6mm),  was used for focusing the UV light to a spot size of ~1.5 mm 
while a separator mounted in front of the lens holder allowed us to position the capillary 
in the focal plane of the lens. A three axis manual micromanipulator was used to align the 
UV.  The capillaries were imaged with a CCD camera positioned at angle 90° to the UV 
source. The schematics of this configuration are shown in the figure below. 
 
 
 
 
 
 
 
 
 
 
Figure 17: Side Illumination Mode 
42 
 
Figures 17-19 shows the configuration for the Side Illumination mode.  In this mode, first 
capillaries are preassembled with stoppers (shown in figure 19) at predetermined 
distances. While taking the reading the capillaries are slid into the sample holder by 
compressing the spring loaded arms of the sample holder. Once they are placed properly 
in the sample holder, the arms of the sample holder are released to hold the capillary 
straight and in place for taking the fluorescence reading Tabs on the sample holder ensure 
that the capillary when placed properly remains at the focal plane of the focusing lens. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18: High Power LED Side Illumination Mode  
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Figure 19: Sample holder and Capillary with stoppers attached  
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4.3 Preparation of Animal Stool Samples 
 
Stool samples from animals fed with Dextran Sodium Sulfate to simulate human Irritable 
Bowel Disease (IBD) were collected and frozen immediately. Myeloperoxidase (MPO) 
present in such stool samples simulating human was extracted by following the protocol 
previously established by Lettesjo et.al74, using a special extraction buffer. 
4.3.1 Extraction Buffer Preparation 
 
The extraction buffer was prepared in such a way that it contains 12mM EDTA, 1% Fetal 
Bovine Serum (FBS), Protease Inhibitor (consisting of AEBSF 0.2 mM, E-64 1.4 µM, 
Bestatin 13 µM, Leupeptin 0.09 µM, Aprotinin 0.03 µM, EDTA 0.1 mM), 20% Glycerol 
and 0.05% Tween 20. When not in use the extraction buffer should be stored at 4oC. 
4.3.2 Stool Sample Preparation Protocol 
 
The stool samples were weighed and diluted by 5 times (vol/wt) by adding extraction 
buffer. The mixture was kept at 4oC for 15 minutes to hydrate the stool sample before 
homogenization. The hydration step was followed by sample homogenization (Tissue-
Tearor Model No.: 985-370, Type 2, Biospec Products Inc) at 5000 RPM till a stable 
suspension could be obtained. Typical time required for homogenization varied between 
15-60 seconds. The homogenized sample was allowed to mix with extraction buffer for 
15 minutes at 4°C, followed by centrifugation at 14000 RPM at 4°C for 30 minutes.  The 
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supernatant was collected without disturbing the pellet and it was stored at -20oC till 
further use.  
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5. RESULTS 
5.1 Primary Antibody Immobilization 
 
Immobilization of the antibody is an important parameter for the performance of a 
biosensor. The amount of antibody that is immobilized on the surface of the biosensor 
determines the performance of the antibody. Before performing any assay inside a 
capillary set up, it was important for us to determine whether the antibody is successfully 
immobilized on the inner walls of the capillary or not and at what concentration we reach 
saturation. In order to achieve this, the pCaps were functionalized with 1N NaOH for 1 
hour and then activated with EDC/NHS solution for 5 hours (see Methods section for 
more details). Once the capillaries were activated, they were incubated with various 
concentration of QD-Ab conjugate for 16 hours at 4oC. The images were captured using 
the Leica Fluorescent Microscope at 10X magnification, 840ms frame speed and 12.2 
gain. The frame speed and gain were chosen such that the CCD camera of the microscope 
saturates when capillaries were filled with just 100Nm QD-Ab solution.   
In this experiment, the activated capillaries were incubated with 10, 25, 50, 100 and 350 
nM of QD-Ab conjugate in triplicates at 4oC for 16 hours.  
The images captured were analyzed using Image J. Briefly, raw images were cropped 
using Photoshop and a fixed size of images was used for measuring the average intensity. 
Figure 20 shows the schematic of image analysis that was used.  
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using Photoshop
 
Figure 20:: Steps in analysis of microscopic images 
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The results from Figure 20 show that we achieve maximum antibody coverage when the 
pCaps are exposed to100nM or higher concentration of antibody. The results from this 
experiment were used in future experiments for carrying out the assay, i.e., for primary 
antibody immobilization, the capillaries were incubated with 100nM of primary antibody 
solution.  
 
Figure 21: Graph shows the binding of various concentration of QD-Ab on the treated 
pCap surface 
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Table 2 shows the intensity values for different concentration of QD-Ab immobilized on 
the surface of the capillary. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QD-Ab Concentration (nM) Average Intensity Standard 
Error 
350 31.78 0.98 
100 29.24 2.52 
50 27.13 3.03 
25 24.94 2.8 
10 20.03 1.63 
 
Table 2: Intensity values of capillaries immobilized with various 
concentrations of QD-Ab 
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5.3. MPO Assay - Proof of Concept 
 
After successfully immobilizing the antibody on the surface of the capillary, it was 
important for us to show that the whole assay can be performed inside the pCaps reliably. 
In order to achieve this, we started with an experiment at higher concentrations of MPO. 
The whole idea behind performing this experiment was to show that the sandwich assay 
can be performed inside the capillaries.  
In this experiment, along with the assay performance, the effect of blocking was also 
evaluated. Two set of pCaps were immobilized with 100Nm primary antibody and one 
set of capillary were incubated with 1X PBS ph 7.4 buffer containing 2% Fetal Bovine 
Serum (FBS). For each set, MPO assay was carried out in triplicates.  
The concentrations of MPO used for this experiment were 10, 100, 250 and 500nM. 
After, MPO capture step the pCaps were incubated with the 500nM QD-Ab. Since, this 
was experiment was done to check whether the assay works or not, we used 500nM QD-
Ab. Except for this experiment, 100nM QD-Ab was used for all other experiments.  The 
images were analyzed using Image J in the same way as mentioned in the previous 
section.  
The results show that the assay worked for both pCaps sets, i.e. with and without FBS 
blocking. However, for pCaps without blocking higher intensity values were obtained. 
The pCaps incubated with blocking agent demonstrated lower (lower by almost 30-50%) 
fluorescence intensity values.  
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Figure 22: Graph showing the intensity values for various concentration of MPO for 
capillaries with and without blocking 
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The difference in intensity values for capillary with and without blocking for various 
concentrations of MPO could have been observed due to the fact that the blocking agent 
occupies vacant space on the surface of capillary, thereby, reducing the chances of non-
specific binding of MPO or QD-Ab on the vacant surface.   
Figure 23 shows the effect of using a blocking buffer during assay. From the figure it is 
clear that the addition of blocking buffer reduces the non-specific binding of either MPO 
or QD-Ab on the walls of the capillary.  
 
 
MPO 
Concentration  
Blocking Standard 
Error 
No Blocking Standard 
Error 
500 130.80 10.33 243.69 6.18 
250 77.87 11.19 125.35 5.93 
100 54.30 6.34 93.75 19.30 
50 41.48 6.90 88.01 9.10 
10 34.89 5.74 35.46 3.56 
0 19.58 1.33 18.01 1.98 
 
Table 3: Intensity values of capillary with and without blocking for various 
concentrations of MPO 
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Figure 23: Comparison of effect on blocking on capillaries with 500nM MPO 
54 
 
 
5.4 Low Power LED Optical Set Up Development 
 
Demonstration of the assay performance as an MPO sensor using the microscope gave us 
enough confidence to develop an optical configuration where we could detect 
fluorescence at lower concentrations of QDs. For initial development of the appropriate 
optics, different concentrations of QD solutions were used in the pCaps instead of 
performing the whole conjugation assay. We evaluated two configurations with the Low 
Power LED:  the waveguide illumination mode and the integrated waveguide mode using 
multiple LEDs.  For the development of the LPLED optical set up the COHU 4900 CCD 
camera was used.  
5.4.1. Wave Guide Illumination Mode 
 
The basic geometry of this particular set up is shown in the materials and methods 
section. In this set up, a spherical mirror was used to reflect the scattering fluorescent 
light from the capillaries towards the detector.  Figure 23 illustrates the set up with a 
spherical mirror. When a PMMA capillary filled QDs is excited, the fluorescent light 
travels in all 360o directions. This happens because of the cylindrical geometry of the 
capillary. In order to gather the maximum possible light from the capillaries, a spherical 
mirror was employed. The capillaries are placed in the focal plane of the mirror such that 
the maximum amount of light gets reflected back towards the detector.  
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In order to evaluate this set up, QD solutions at concentrations of 0.5, 1, 2.5, 5 and 10nM 
were used. For each concentration, the data was gathered in triplicate.  
The images were captured using COHU 4900 camera with shutter speed at 8ms. The 
average intensity for each image captured by the camera was calculated using a Matlab 
 
Figure 24: The schematic demonstrates the use of a spherical mirror in the set up 
for directing the stray fluorescent towards the detector 
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Code. An image size of 300 x 200 pixels was taken for analysis. Graph in Figure 25 
demonstrates a linear relationship between the intensity at various QD concentrations.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 25: The response of the optical set up for various concentrations of QD solutions 
QD Concentration Average Intensity Standard Error 
10 49.29 0.70 
5 39.40 0.25 
2.5 36.62 0.36 
1 33.57 0.82 
0.5 29.94 2.67 
0 27.78 0.63 
 
Table 4: Intensity value for various concentrations of QD solutions
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The results show a linear relationship between fluorescence intensity and QD 
concentration with a correlation coefficient R2 value of 0.92. From the results of this 
experiment it can be concluded that this optical configuration is adequate in quantifying 
low concentrations of QDs 
 
5.4.2 Multiple LED Integrated Waveguide Mode 
  
Once the waveguide illumination mode was established, the next goal was to increase the 
fluorescence signal from the capillaries by increasing the power of the excitation source. 
In order to achieve this, an array of 15 Low Power LEDs was used to excite the QDs in 
the capillary and the fluorescence signal was collected along the length of the capillary. 
Figure 25 shows the schematic of this set up.  
 
 
 
 
 
 
 
Figure 26: Figure showing multiple LED array set up. In this 
set up the signal was collected at the end of the capillary unlike 
the previous set up.  
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To test this set up for one specific concentration of QD solution, one set of capillaries 
were filled with 2.5nM QD solution and the second set of capillaries were filled with PBS 
pH 7.4 Buffer. The images were captured using the COHU camera and the average 
intensity value for each capillary was calculated. 
 
 
 
 
 
 
 
 
 
The results (Figure 27) show that there is hardly any difference between the intensity 
values of blank and capillaries loaded with 2.5nM QD solutions. This set up was not 
tested further for other QD dilutions because the ratio between the intensity of blank and 
2.5Nm QD solution was 1.02, whereas the ratio between the intensity of value of the 
Figure 27: Comparison of intensities for capillaries filled with buffer and 
1nM QD solution 
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waveguide mode was 1.32. In this set up, only a circular 6 x 6 pixel size window could be 
used for analysis. This made the analysis part really difficult.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QD Concentration (nM) Intensity Standard Error 
Blank 236.1 0.55 
1nM 241.7 1.12 
 
Table 5: Intensity value for 2.5Nm QD and capillaries filled with PBS Buffer 
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5.5 Low Power LED MPO Assay 
 
The goal of this experiment was to perform the sandwich assay and determine the lowest 
detectable level of MPO inside the capillary using the successful waveguide illumination 
mode.  
In this experiment, 0.1, 0.5, 1, 2.5, 5 and 10nM concentrations of MPO solutions were 
used to test the sensitivity of the sensor. The assay was performed in duplicates for each 
concentration and for each test 5 capillaries were used. The images were captured using 
the COHU 4900 CCD camera with a shutter speed of 16ms and the average intensity of 
each image for a window size of 300x200 pixels was calculated.  
 
 
 
 
 
 
 
 
 
MPO Concentration (nM) Intensity Standard Error 
10.0 85.46 1.46 
5.0 76.01 1.91 
2.5 71.77 1.16 
1.0 67.04 0.63 
0.3 62.25 1.04 
0.1 55.12 0.92 
0.0 45.76 1.66 
 
Table 6: Intensity value for various concentrations of MPO obtained using 
waveguide illumination mode. 
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Figure 28 demonstrates a non-linear relationship between the concentrations of MPO in solution 
and the fluorescence intensity obtained using the capillary in a waveguide mode with LPLED as 
the excitation light source. Detection down to 0.1Nm (100 pico molar) is possible; however, the 
resolution of the system decreases as the concentration of MPO decreases.  
Figure 28: The graph shows the sensitivity of the sensor towards MPO at various 
concentrations. 
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We believe that the loss in resolution at lower concentrations stems mostly from 
limitations in the optical hardware i.e. our CCD camera, an analog camera with 
maximum integration time (shutter speed) of 16 ms. In addition; the low power of LED is 
another factor which affects the level of excitation of the QDs. Furthermore, perfect 
alignment of the capillary on the focal plane of the mirror and the proper coupling of light 
from excitation source is extremely difficult.  
In order to overcome the limitations of the LPLED set up, a high power LED was used 
and different excitation modes were tested. 
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5.6 Development of the High Power LED Optical Configuration 
 
The goal of this experiment was to establish an optimal optical detection set up which 
works for HPLED. For the HPLED optical set up development two modes of illumination 
were tested:  the Waveguide mode and the side illumination mode as described in the 
materials and methods section.  
In this experiment 0.05, 0.1, 0.5 and 1nM concentrations of QD solutions were used for 
testing the efficacy of the two excitation modes. An aspherical lens was used to focus the 
LED light on the capillaries. The reason for using the lens was to increase the optical 
power incident on the capillaries. When the HPLED is used without a lens then its optical 
output is ~80mW/cm2 whereas in combination with a lens the output is 190 mW/cm2. 
The optical output of the High Power LED was measured using UV Power Meter. In this 
experiment, the fluorescence intensity at various locations of the capillary with side 
illumination was collected by moving the excitation source that was mounted on a 
translation stage. This allowed us to collect at a rapid rate statistically reliable data from 
individual capillaries mounted on a custom made spring loaded sample holder, which 
kept the capillary stretched and aligned. Figure 29 shows the set up, the UV LED is 
mounted on to a 3 axis macro-manipulator. The UV LED is moved along the length of 
the capillary to excite the QDs inside the capillary.  
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Figure 30 shows the effect of mode of excitation on pCaps loaded with QD solutions.  
 
 
Figure 29: High Power LED Side Illumination Mode  
Concentration  
(nM) 
Waveguide 
Mode 
Std 
Error 
Side Illumination 
Mode 
Std 
Error 
1 40.3 1.20 153.33 14.52 
0.5 33.3 1.76 82.50 0.41 
0.1 19.0 1.00 28.00 2.31 
0.05 18.0 0.00 19.67 1.20 
0 16.3 0.33 16.33 0.33 
 
Table 7: Intensity values for various concentrations of QD using two modes 
excitation. 
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The advantages of side illumination can be clearly seen although the difference 
diminishes at concentrations below 100 picoMolar (0.1nM).   
For the side illumination mode the fluorescent intensity was higher than with the 
waveguide illumination mode. The loss in fluorescence in the waveguide mode can be 
attributed to several factors: 1) optical misalignment in the waveguide mode leading to 
reduced light coupling efficiency, 2) insufficient path length resulting in decreased 
fluorescence volume and 3) most importantly due to the higher refractive index of the 
PMMA capillary compared to the refractive index of the buffer inside the capillary, 
hence, the PMMA capillary doesn’t work as a perfect waveguide for illuminating the 
QDs in the solution.  
 
 
 
 
 
 
 
 
 
Figure 30:  Shows the comparison of fluorescence intensities of QD solutions 
obtained with side illumination and waveguide modes. pCaps were inserted inside 
a glass capillary when imaging in the waveguide mode. 
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Side illumination on the other hand results in exciting almost all of the QDs in a volume 
of ~50nL (beam diameter = 1mm) and this could be the main reason for the observed 
difference in intensities between the two illumination modes at relatively higher 
concentrations (>100 pM). As the concentrations approach the 50pM range the difference 
in intensity is practically zero. Hence, for our purpose side illumination appears to be a 
better choice due to its simplicity and superior performance. 
From this experiment onwards, side illumination mode was employed for all future 
experiments with HPLED (~190Mw/cm2) as the excitation source. 
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5.7 Primary Antibody Circulation Experiment 
 
As mentioned earlier, antibody immobilization is a critical component of a biosensor’s 
performance and it is affected by various factors. One such factor is the mixing of the 
antibody solution to provide a homogeneous and continuous supply of antibody and 
accelerate the immobilization process. When antibody is circulated through capillaries it 
can reach the surface of the capillary faster and adsorption on the polymer surface is 
accelerated resulting in faster immobilization rates. In this experiment, we explored the 
effect of a static immobilization process versus a dynamic flow and measured the effect 
on the rates of antibody immobilization.  The main goal of the experiment was to reduce 
the time required for the antibody immobilization step. In order to achieve this, after 
initial capillary activation, for one set of capillaries the primary polyclonal antibody was 
circulated through the capillary using the peristaltic pump at 30µL/min. For the second 
set, the capillaries were filled with primary antibody solution and left at 4oC for 16 hours. 
Following antibody incubation, both sets of capillaries were incubated with 10nM MPO 
to check the effect of circulation on sensor performance. 
The images were captured using the COHU 4900 camera and the images were analyzed 
using Image J to calculate the average fluorescence intensity values. 
Figure 31 shows that all capillaries where the antibody was circulated for the 
immobilization step had higher intensity values compared to the capillaries where static 
immobilization was employed. 
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Figure 31: Effect of circulation on during antibody immobilization process 
 
 Average Intensity Standard 
Error 
Circulation 80.67 5.51 
No Circulation 60.83 6.22 
 
Table 8: Comparison of intensity values for capillaries with and without 
primary antibody circulation step. 
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This result confirms that at least the antibody circulation at room temperature for one 
hour doesn’t affect the sensor performance adversely and hence, it can be employed in 
future experiments to bring down the capillary preparation time from 22 hours to merely 
7 hours. Initially, the capillary activation step was for 5 hours and the antibody 
immobilization use to take 16 hours. Now the antibody immobilization step takes just one 
hour, hence, this reduced the capillary preparation time to 7 hours from 22 hours. In order 
to save time in capillary preparation in future experiments, the antibody solution was 
circulated through the capillary for one hour.  
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5.8 High Power LED MPO Assay 
 
After successfully identifying an optical configuration and a satisfactory immobilization 
scheme, we proceeded to translate these improvements into a full MPO immunoassay at 
lower concentrations. From the previous results we gained enough confidence that the 
changes implemented can improve our signal to noise ratio at lower concentration of 
MPO, i.e, 100 pico molar. In order to further improve the signal to noise ratio we used, 
for all subsequent experiments the Stingray CCD camera which has with superior 
features compared to the COHU CCD camera. 
MPO concentrations of 1, 0.5 and 0.1nM were prepared in duplicates (Total N = 9) and 
the assay was performed inside antibody immobilized capillary. Fluorescence intensity at 
various locations on a capillary was collected by moving the excitation source that was 
mounted on a translation stage. The images were captured at an integration time of 100 
µs with maximum gain and shutter speed of the camera. The captured images were 
analyzed with Image J. A window size of 30x15 was use to calculate the average 
intensity between the two bands of the capillary.  
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Figure 32: Fluorescence intensity at various MPO concentrations obtained by side 
illumination 
 
Concentration (nM) Intensity Standard Error 
1 201.94 7.18 
0.5 128.81 12.42 
0.1 81.08 5.51 
0 48.20 2.85 
 
Table 9: Intensity values for various concentrations of MPO for High Power 
LED set up 
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Figure 32 shows the improved performance of the sensor at lower concentrations of 
MPO, i.e., the ratio between the signals of blank and 0.1nM MPO is almost 1:2, which is 
much better than the waveguide mode set up employed in the case of LPLED, where the 
signal to noise ratio was 1:1.3.  
Figure 33 shows the comparison of LPLED waveguide set up and HPLED side 
illumination set up. From the graph we can see a better signal to noise ratio in case of 
HPLED set up.  
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Figure 33: Comparison of LPLED side illumination with HPLED waveguide 
geometry: Intensity values are corrected by the control intensity 
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Figure 34 shows spot free images for lower concentrations of MPO. These images were 
captured at various locations on a capillary and demonstrate uniformity of the 
fluorescence signal. The bands that appear in the CCD images are result of the 
architecture of the optical set up and capillary geometry. The intensity from the bands of 
the capillary were not used in analysis because they represent the leakage of UV light 
through the band pass filter.   
 
 
 
 
 
Figure 34: CCD image of control and 100pM MPO at three 
different spots 
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5.9 NHS vs Sulfo-NHS Treated Capillaries 
 
The primary purpose of this experiment was to evaluate the effect of using sulfo-NHS 
versus using NHS along with EDC for antibody immobilization. The non-sulfonated 
NHS is less water soluble and hydrolyzes faster in water compared to the sulfonated-
NHS. The main advantage of using sulfo-NHS in EDC reactions is to increase the 
stability of the active intermediate of EDC during the covalent bonding formation process 
with either amine or carboxyl group. In this experiment, we tried to explore the effect of 
sulfo-NHS use on sensor performance.  
In this experiment, 30mM of EDC and NHS solutions were prepared in PBS pH 6.0 
buffer. After NaOH functionalization of the capillaries, the capillaries were activated 
with EDC/Sulfo-NHS instead of EDC/NHS solution. The EDC/sulfo-NHS solution was 
circulated through the capillary for 1 hour at room temperature followed by circulation of 
100nM primary antibody solution for 1 hour at room temperature  Once the capillaries 
were ready, the whole sandwich assay was carried out to see the effect of sulfo-NHS use 
on the sensor performance for detecting 0.1, 0.5 and 1nM MPO. 
From Figure 35 it is clear that there is a good correlation of fluorescent intensity values 
between sulfo-NHS and NHS treated capillaries. This was further confirmed by 
performing a t-test on the intensity values at different concentration. The p value obtained 
from the t-test was ~0.95, which is greater than 0.05, hence, statistically there is no 
significant difference between the two groups. 
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Figure 35: Comparison of fluorescence intensity at various concentration of MPO 
for NHS and Sulfo-NHS treated capillaries 
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Hence, it can be concluded that the use of sulfo-NHS didn’t affect the performance of the 
sensor. However, the use of sulfo-NHS reduced the capillary preparation time from 7 
hours to 3 hours. This reduction in time happened because in previous experiments 
EDC/NHS was circulated for 5 hours at room temperature however, EDC/Sulfo-NHS is 
circulated for 1 hour thereby reducing the capillary preparation time from 7 hours to 3 
hours. 
 
 
 
 
 
 
 
Concentration (nM) Intensity Std Error Intensity Standard Error 
 Sulfo-NHS NHS p -value 
1 207.83 7.963458 201.94 7.18 0.95 
0.5 126.75 4.597705 128.81 12.42  
0.1 75.5 4.327721 81.08 5.51  
0 36.75 3.037954 48.20 2.85  
 
Table 10: Comparison of Intensity values for various concentration of MPO treated 
with NHS and Sulfo-NHS. P-value obtained after performing t-test gives the 
correlation between two groups. 
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5.10 Assay Specificity Test 
 
The purpose of the following experiment was to test the specificity of the sensor and the 
assay. To test the specificity, instead of MPO alone Human Matrix Metalloproteinase I 
(MMP 1) was used in the same experiment. Since the polyclonal antibody (capture 
molecule) and the monoclonal antibody (reporter molecule) will bind only to MPO, we 
shouldn’t be seeing any fluorescence from the capillaries infused with MMP 1. 
The experiment was divided into two sets. In the first set of experiments, the immobilized 
capillaries were incubated with 150 ng/mL of MMP 1. In the second set of experiments, 
the capillaries were immobilized with a solution containing a mixture of 50:50 MMP 1 
and MPO at a total concentration of 150 ng/mL each.  The goal of the second experiment 
was to check whether the sensor can detect MPO in the presence of another biomolecule.  
The results show that the sensor can detect successfully MPO in the presence of MMP 1. 
The capillaries which were incubated with MMP 1 alone had slightly higher intensity 
value than the negative control capillaries. This could be due to the non-specific binding 
of QD-Ab on the surface of capillary tube or   a certain degree of non-specificity of the 
antibodies for MMP 1.  
This experiment illustrates the specificity of the antigen/antibody reaction for this 
particular sandwich assay. 
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Figure 36: Comparison of fluorescence intensity from capillaries with MMP and 
MMP+MPO containing 150ng/mL of MMP and MPO. 
 Intensity Standard Error 
MMP 47.94 1.40 
MMP - MPO 163.71 10.77 
Control 34.71 2.12 
 
Table 11: : Comparison of fluorescence intensity from capillaries with MMP and 
MMP+MPO containing 150ng/mL of MMP and MPO. 
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5.11 Spiked Animal Sample 
 
The next step in validating the sensor and the assay was to test their performance in a 
more complex system simulating clinical samples. Presence of various biologically 
relevant moieties that are present in the animal stool samples is a major concern in 
developing a sandwich assay since the entire assay relies on the specificity and cross 
reactivity of the polyclonal (capture antibody) and the monoclonal antibody (reporter 
molecule) towards the antigen. Sensitivity of the QLISA protocol thus depends on the 
sensitivity and specificity towards one another in the pAb/MPO/QD-Ab sandwich. 
Although chemistry optimization steps were taken to minimize nonspecific interactions 
between the sensor substrate and the analyte, it is imperative that the robustness of the 
protocol and the device be evaluated with actual samples rather than solutions of the 
antigen.  
The assay protocol was tested in spiked animal stool samples to evaluate its ability to 
detect MPO at trace levels in biological samples. Stool samples from disease-free mice 
were collected and prepared as described in the Materials and Methods section. The 
extract obtained served the purpose of being the control and external MPO was added to 
the extract (spiking). The stool sample extract was spiked such that the final 
concentration of MPO in the extract was 1, 0.5 and 0.1nM respectively. In order to get an 
extract with 1nM external MPO, 10 µL of external MPO (10 nM) was added to 90 µL of 
the stool extract and so on. In this mouse model (Karwa et al. 2007), before inducing 
disease, the animals bear no MPO in their stools. Intensity values of MPO obtained from 
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the spiked stool extracts were then compared with the intensities from MPO dilution 
experiment done previously.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 37: Fluorescence intensity from spiked animal stool samples. 
Fluorescence intensity values obtained from spiked animals were compared with 
fluorescence intensities of MPO in solution. 
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Figure 37 shows the fluorescence intensity data from stool samples collected from the 
animals along with data from MPO in solution (standard curve). Spiked stool samples 
exhibit response that is similar to that of MPO in solution, illustrating the specificity of 
the antigen/antibody complex and the robustness of the assay protocol. The intensity 
value obtained from the stool sample that does not contain any MPO is essentially the 
same as the control capillaries of the MPO solution set, indicating the absence of non-
specific interaction between the capture antibody and/or the mAb. This was further 
confirmed by the t-test results; with p > 0.94 indicate that there is statistically no 
difference between the two data sets. 
 
 
 
MPO 
Concentration 
(nM) 
Spiked Animal 
Sample 
Standard 
Error 
Standard 
Curve 
Standard 
Error 
p-value 
1 198.35 13.36 201.94 7.18 0.94 
0.5 136.78 4.36 128.81 12.42  
0.1 90.78 4.45 81.08 5.51  
0 48.84 5.85 48.20 2.85  
 
Table 12: Comparison between the intensities of Spiked Animal Data and MPO 
Standard Curve 
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5.12 Animal Samples 
 
The spiked animal data were considered as an encouraging first step towards using this 
assay in a full disease model to quantify the presence of MPO in stools. The mouse 
model and the use of QDs to evaluate inflammation, established by Karwa et al63 were 
used for this experiment.  
Stool samples were collected on different days after induction of colonic  inflammation in 
mice. For this experiment, stool samples collected before induction of inflammation (Day 
0), on day 5 and on day 7 of inflammation were used for analysis. For Day 7, samples 
from 5 animals were used for analysis and for Day 0 and Day 5, samples from 3 animals 
were used. The assay run was repeated twice and each run was performed in triplicate.  
Figure 38 shows the results of the assay for animal samples collected at different days. 
We can see a clear difference in the level of fluorescence intensity for Day 7 samples 
when compared with the Day 5 and Day 0 samples. This is observed due to the over 
expression of MPO in animals after they are fed with Dextran Sulfate Sodium (DSS) for 
7 days. This result shows that the sensor and the assay protocol developed can 
differentiate between diseased animals with inflammation and healthy animals.  
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Figure 38: Comparison of Intensity values for stool samples collected on 
different days after induction of inflammation.  
 Intensity Standard Error 
Day 7 87.45 4.35 
Day 5 49.61 1.09 
Day 0 37.22 2.38 
Table 13: Comparison of intensity for various samples collected on various days 
after induction of inflammation. 
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To further confirm the reliability of the assay and the sensor, ELISA was performed on 
the stool samples.  
For an ELISA assay 100µL of sample is required, therefore we could only perform the 
ELISA assay  on 4 samples from Day 7, one sample from Day 5 and 3 samples from Day 
0. For this experiment, the Zen Myeloperoxidase Kit purchased from Invitrogen was 
used.  
Figure 39 shows the comparison of in-house MPO assay and ELISA. For day 7 samples, 
ELISA detected ~7.5 ng/mL of MPO in prepared stool aliquots, whereas, the in-house 
MPO assay detected ~13ng/mL of MPO.  
 
 
 
 
 
 
 
 
 
 
Figure 39: Comparison of detection of MPO by a commercial 
ELISA kit and QD-Assay for Day 7 diseased samples 
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From the results it can be concluded that a similar pattern was observed for both ELISA 
and in-house MPO assay. Even though the assay and the sensor developed in the lab 
showed 77% higher concentration of MPO than the commercial ELISA kit for Day 7 
samples. However, when t-test was performed no statistically significant differences 
between the two results were observed. This shows that there is a fair correlation between 
the two results. 
The higher value of MPO level in the sensor could have been detected due to several 
factors: 1) For each pair of antibody/antigen the affinity varies and the antibodies used in 
commercial ELISA and in-house assay were different and this would account for the 
observed differences. 2) Non-specific binding of QD-Ab to various biological molecules 
in the stool sample or to the walls of the capillary could have contributed to a higher level 
of MPO detection.  
Day 7 Sample  MPO (ng/mL)  Standard Error  p‐value 
QD‐Assay  12.67  1.92  0.17 
ELISA  7.14  1.93   
 
Table 14: Comparison of performance of in-house QD-Assay and ELISA for 
Day 7 samples. p value of 0.17 (p>0.05) shows that there is no statistically 
significant difference between the commercial ELISA kit results and in-house 
QD-Assay 
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6. Discussion 
 
The unique optical properties of QDs such as broad excitation spectra, narrow emission 
spectra, large Stokes Shift, high resistance to photobleaching, higher photo-stability and 
stronger fluorescence makes them one of the most attractive fluorescent reporter 
molecules for a wide range of biological applications including biosensing and assay 
development applications76. However, the higher cost of QDs has limited their 
application in biology. One such application is the development of assays. Usually, 
bioassays are carried out in 96 well plates which require at least 50 - 100µL of sample 
and reagents. The most common method followed for plate based assays is Enzyme 
Linked Immunosorbent Assay (ELISA). In order to capitalize on the superior properties 
of QDs we devised a capillary based immunosensor utilizing just 1-2µL of sample and 
reagents for detection of biomarkers thereby reducing the cost of reagents in the whole 
process. Also, a free standing capillary tube offers superior simplicity in manufacturing 
and handling compared to developing a full scale lab-on-a-chip type device.  In order to 
test and demonstrate whether a capillary based sandwich immunoassay and the use of 
QDs could be integrated to detect an antigen, we targeted a ubiquitous inflammation 
marker Myeloperoxidase (MPO). We demonstrated the detection of MPO with QDs as 
reporter molecules inside the capillaries by using a fluorescent microscope. Even though 
very high concentration of MPO was used to demonstrate this, still it gave enough 
confidence to develop an optical set for detection of fluorescence from the capillary. The 
effect of using an optimal concentration of blocking agent was explored. Regions of 
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higher QD intensity in the absence of blocking agent were observed because after 
antibody immobilization few vacant sites remain which contribute to non-specific 
binding of QD-Ab. In order to overcome this, Fetal bovine serum (FBS) was added to the 
buffer which binds non-specifically to the vacant sites on the inner surface of the pCap 77. 
This experiment suggested that the QD based assay can be used to detect MPO.  
In the next experiment the optimal optical set up was explored for detection of 
fluorescence from capillaries containing MPO. Two set ups i.e., waveguide mode and 
multiple array mode excitation were explored and it was found that the waveguide mode 
was better because of significantly reduced noise compared to the multiple LED array. 
The LED array was expected to give better results than the waveguide illumination mode; 
however, this failure can be attributed to the destructive interaction of photons from each 
LED there by leading to reduced excitation power. After the development of the optical 
configuration, the lowest limit of detection of MPO was explored using the waveguide 
illumination mode. A non-linear relationship was obtained for various concentrations of 
MPO. Even though the lowest limit of detection was found to be 0.1nM, the signal to 
noise ratio deteriorated rapidly for concentrations below 1nM MPO. This loss in signal 
intensity could be attributed to the limitation of the CCD camera (maximum 16ms shutter 
speed) and also to the alignment of the capillary. The capillary should always be aligned 
properly on the focal plane of the spherical mirror in use and also, it should be aligned 
along the UV excitation source for maximum coupling of light.  
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In order to overcome these challenges, a new high power LED was used along with an 
apsherical lens to establish a side-illumination mode of excitation. This mode of 
excitation gave superior results and it addressed the issue of complex alignment of the 
capillary along the axis of the light source for maximum coupling of light into the 
capillary. In this case, the alignment was very simple and straightforward and only a 
small portion of capillary is excited by the light which results in excitation of almost all 
QDs in that particular region leading to higher intensity value.   
In the next experiment, continuous flow / mixing of the antibody was explored to 
evaluate its effect on primary antibody immobilization. It was found that in the case of 
continuous flow immobilization higher fluorescent intensities were observed. Mixing of 
antibody molecules resulted in their rapid movement towards the surface of the 
substrate78 and facilitated faster immobilization on the polymer surface.  In the next two 
experiments, a standard curve for the MPO assay at lower concentrations was established. 
It was observed that for High Power side-illumination mode the signal to noise ratio 
better and for 100 picomolar MPO was higher by 350%.when compared with the Low 
Power LED Waveguide Mode results. This was due to higher power of excitation beam 
incident on the capillary.  
In addition to sensitivity, specificity is the most important aspect of any assay 
development or immunosensor development process. Given the multitude of things 
happening in a human body it is important to determine the specificity of the 
antigen/antibody reaction of the system. In order to test the specificity of the developed 
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assay, we tested its performance in the presence of another biomolecule MMP-1. The 
sensor was able to detect MPO in the presence of MMP 1 without giving any false 
positive result. This was followed up by a more complex system. External MPO at 
various concentrations were added to stool samples from control animals.  The spiked 
stool samples exhibited response similar to that of MPO in solution, further illustrating 
the specificity of the antigen/antibody complex and the robustness of the assay protocol.  
In the next experiment, stool samples from healthy and diseased animals (with 
inflammation due to simulated colitis) were used for checking the performance of the 
quantum dot based micro-capillary assay. By taking advantage of QDs we were able to 
detect the MPO in just one micro liter of sample from diseased animals. The results 
obtained from our experiments were compared with those of a commercial ELISA kit for 
MPO. The ELISA results further corroborated the performance of the QD assay 
developed for MPO detection. t-Test further confirmed that there is no statistically 
significant difference between the two assay results for Day 7 samples.  
One of the major hurdles which our micro capillary assay faces could be the limit of 
detection. Even though our assay is able to differentiate between diseased and healthy 
samples, from a diagnostic point of view we would like to be able to monitor disease 
progression. With the current set up and the current limit of detection this cannot be 
achieved with the desired sensitivity. In order to achieve this, various parameters such as 
superior antibody immobilization process, increase in sample volume (from 1 to 5 
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microliters) and a superior optical set up are some areas where improvements can be 
made to enhance the performance of the QD capillary immunoassay.   
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7. Conclusion 
 
A PMMA polymer capillary based assay has been developed which is capable of 
detecting analytes at picomolar level in micro liter volumes. The capillary immunosensor 
and the QD assay was developed and tested with Myeloperoxidase, a marker that is over 
expressed in the case of inflammation. The sandwich assay for MPO was first validated 
using a microscope. After this validation, different optical set ups were tested to establish 
the best performance of the system. Primarily, two different geometries, i.e., waveguide 
illumination mode and side illumination mode were used to excite the QDs inside the 
capillary either by using a high power LED or low power LED. The lowest limit of 
detection which could be achieved with this platform was approximately 100 picomolar 
(~15ng/mL) of MPO in solution for both High Power and Low Power LED. However, 
High Power LED side illumination mode performed better in terms of signal to noise 
ratio at lower concentrations. The side illumination mode also eliminated the problems 
pertaining to optical alignment. The results obtained indicate that the QD assay can be 
effectively used inside a microcapillary to detect analytes in biological samples such as 
stool samples and is capable of differentiating the diseased animals from the healthy 
ones. The result of the capillary based QD assay correlated well with commercial ELISA 
kit for determining the level of MPO in diseased animal stools samples. Hence, it can be 
concluded that the advantages of capillary based assay and superior photo-physical 
properties of QDs were integrated successfully developed and tested with MPO. The 
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main advantages are small sample volume (~1-2µL) and reagent volumes (~10 µL) and 
inexpensive optics.  
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8. Future Work 
 
In this research work, we successfully developed a Quantum Dot Based Microcapillary 
Immunosensor for detection of MPO, thereby laying foundation for future developments. 
There are various aspects on which improvements can be made in order to make the 
immunosensor more sensitive and high throughput.  
In order to improve the sensitivity of the immunosensor various things can be employed. 
First and foremost, the amount of antibody immobilization on the surface of the antibody 
can be increased by using a non-zero crosslinker to enhance the sensor performance. Bai 
et al reported a study where they compared the effect of using a non-zero cross linker   
poly(ethyleneimine) PEI with a zero length cross linker Hexamethylene Diamine (HMD) 
on antibody immobilization on the surface of PMMA and its subsequent effect on the 
performance of the sensor75. They reported that the PEI greatly improved the sensor 
performance mainly due to the spacer effect which it provided for antibody 
immobilization. Hence, in future by using non-zero length crosslinker we can increase 
our immunosensor performance.  
One more way of increasing the sensor performance by using a different Quantum Dot 
probe, for e.g., streptavidin conjugated QD and biotinlyated secondary antibody. A study 
reported by the Zajac et al showed that the use of biotinlyated antibody and streptavidin 
QDs instead of QD-Ab conjugate increased their sensor performance level significantly59. 
They reported detection in picograms/mL range (femtomolar region). Hence, in future 
this can be employed to check whether the sensor performance increases or not. 
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However, the main disadvantage of this method is the extremely high cost of the 
reagents.    
One more way of improving the sensor performance is by using expensive optical set up 
hardware’s like a Laser excitation source and sensitive Photo Multiplier Tubes. However, 
use of these equipments will considerably increase the cost of the optical set up.  
In the current set up, we are handling only one capillary at a time. Due to this the data 
acquisition process is very slow and labor intensive. In order to make this system high 
throughput, a multiple capillary holder set up can be devised in future to carry out the 
assay thereby making it fast, portable and automated.  
All the above ideas can be implemented in future to improve the performance of the 
current QD based microcapillary immunosensor.  
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